Clinical Trials
Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease
Amicus Therapeutics announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research Institute (AWRI) at Nationwide...
Press Releases
Pre-scored chip substrates provide new options for manufacturers of innovative diagnostic consumables
SCHOTT NEXTERION® PreScora will be featured at the American Association of Clinical Chemistry’s annual scientific meeting and clinical lab expo in Anaheim, Ca.
Biotech companies...
Industry Reports
Medigene AG Medigene reports financial & business results for the first six months of 2019
Medigene AG , a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, reported on their business performance and financial results...
IT & Data Management
The “Papageorgiou” General Hospital of Thessaloniki joins Clinerion’s hospital network, consolidating Patient Network Explorer coverage in Greece
Geniko Nosokomeio Thessalonikis “Papageorgiou” brings its patients and physicians quicker access to innovative medical treatments by joining Clinerion’s Patient Network Explorer platform.
Based in the...
Interviews
Can an alternative drug delivery system finally help realise the potential of cancer vaccines?
1. Recent studies suggest great therapeutic potential of educating and unleashing our own immune system for cancer treatment; is this a holistic way forward?
Many...
IT & Data Management
GNA Biosolutions Closes 13.5M Series C Financing Round Backed by a US EU consortium
GNA Biosolutions GmbH, a molecular diagnostics company based in Germany, announced that it has completed a $13.5M round of financing.
The Series C financing round...
Clinical Trials
GlycoMimetics Reports Top-line Results From Pfizers Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease
GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal study did...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read